| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Common Shares | Sale | -$2.52K | -126 | -0.09% | $20.00 | 142K | 13 Sep 2024 | As trustee of the Allibhoy Khaishgi Family Foundation | |
| transaction | IBEX | Common Shares | Sale | -$2K | -100 | -0.03% | $20.00 | 322K | 13 Sep 2024 | Direct | |
| transaction | IBEX | Common Shares | Sale | -$202K | -10K | -7.03% | $20.25 | 132K | 16 Sep 2024 | As trustee of the Allibhoy Khaishgi Family Foundation | F1 |
| transaction | IBEX | Common Shares | Sale | -$254K | -12.6K | -3.91% | $20.19 | 310K | 16 Sep 2024 | Direct | F1 |
| transaction | IBEX | Common Shares | Sale | -$145K | -7.25K | -5.48% | $20.01 | 125K | 17 Sep 2024 | As trustee of the Allibhoy Khaishgi Family Foundation | F2 |
| transaction | IBEX | Common Shares | Sale | -$165K | -8.27K | -2.67% | $20.00 | 302K | 17 Sep 2024 | Direct | F3 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $20.00 to $20.45; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F2 | This transaction was executed in multiple trades at prices ranging from $20.00 to $20.075; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| F3 | This transaction was executed in multiple trades at prices ranging from $20.00 to $20.05; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |